These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36303048)

  • 41. Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis.
    MacDonald KG; Dawson NAJ; Huang Q; Dunne JV; Levings MK; Broady R
    J Allergy Clin Immunol; 2015 Apr; 135(4):946-955.e9. PubMed ID: 25678090
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of regulatory T Cells in autoimmune orchitis.
    Jacobo P
    Andrologia; 2018 Dec; 50(11):e13092. PubMed ID: 30569653
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induction of antigen specific CD4(+)CD25(+)Foxp3(+)T regulatory cells from naïve natural thymic derived T regulatory cells.
    Hall BM; Tran GT; Robinson CM; Hodgkinson SJ
    Int Immunopharmacol; 2015 Oct; 28(2):875-86. PubMed ID: 25882104
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Innate Immunity Protein Tag7 Induces 3 Distinct Populations of Cytotoxic Cells That Use Different Mechanisms to Exhibit Their Antitumor Activity on Human Leukocyte Antigen-Deficient Cancer Cells.
    Sharapova TN; Ivanova OK; Soshnikova NV; Romanova EA; Sashchenko LP; Yashin DV
    J Innate Immun; 2017; 9(6):598-608. PubMed ID: 28977785
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The Role of Regulatory T-cells in Antitumor Immune Response].
    Klabusay M
    Klin Onkol; 2015; 28 Suppl 4():4S23-7. PubMed ID: 26647885
    [TBL] [Abstract][Full Text] [Related]  

  • 46. GPA33: A Marker to Identify Stable Human Regulatory T Cells.
    Opstelten R; de Kivit S; Slot MC; van den Biggelaar M; Iwaszkiewicz-Grześ D; Gliwiński M; Scott AM; Blom B; Trzonkowski P; Borst J; Cuadrado E; Amsen D
    J Immunol; 2020 Jun; 204(12):3139-3148. PubMed ID: 32366581
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ability of mature dendritic cells to interact with regulatory T cells is imprinted during maturation.
    Muthuswamy R; Urban J; Lee JJ; Reinhart TA; Bartlett D; Kalinski P
    Cancer Res; 2008 Jul; 68(14):5972-8. PubMed ID: 18632653
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development and Function of Effector Regulatory T Cells.
    Teh PP; Vasanthakumar A; Kallies A
    Prog Mol Biol Transl Sci; 2015; 136():155-74. PubMed ID: 26615096
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CD28 signals the differential control of regulatory T cells and effector T cells.
    Mikami N; Sakaguchi S
    Eur J Immunol; 2014 Apr; 44(4):955-7. PubMed ID: 24652756
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activation of regulatory T cells instigates functional down-regulation of cytotoxic T lymphocytes in human breast cancer.
    Li CH; Kuo WH; Chang WC; Huang SC; Chang KJ; Sheu BC
    Immunol Res; 2011 Oct; 51(1):71-9. PubMed ID: 21918886
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The potential role of regulatory T cells in postburn sepsis].
    Yao YM; Huang LF
    Zhonghua Shao Shang Za Zhi; 2011 Apr; 27(2):81-3. PubMed ID: 21651840
    [TBL] [Abstract][Full Text] [Related]  

  • 52. What are regulatory T cells (Treg) regulating in cancer and why?
    Whiteside TL
    Semin Cancer Biol; 2012 Aug; 22(4):327-34. PubMed ID: 22465232
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Colorectal Cancer-Infiltrating Regulatory T Cells: Functional Heterogeneity, Metabolic Adaptation, and Therapeutic Targeting.
    Aristin Revilla S; Kranenburg O; Coffer PJ
    Front Immunol; 2022; 13():903564. PubMed ID: 35874729
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interplay between pathogenic Th17 and regulatory T cells.
    Oukka M
    Ann Rheum Dis; 2007 Nov; 66 Suppl 3(Suppl 3):iii87-90. PubMed ID: 17934104
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting of TLRs inhibits CD4+ regulatory T cell function and activates lymphocytes in human peripheral blood mononuclear cells.
    Voo KS; Bover L; Harline ML; Weng J; Sugimoto N; Liu YJ
    J Immunol; 2014 Jul; 193(2):627-34. PubMed ID: 24928999
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lymphocytes and thyroid cancer: more to it than meets the eye?
    Weber F
    Endocr Relat Cancer; 2014 Jun; 21(3):C1-5. PubMed ID: 24825745
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Regulatory T cells in chronic obstructive pulmonary disease].
    Limón-Camacho L; Solleiro-Villavicencio H; Pupko-Sissa I; Lascurain R; Vargas-Rojas MI
    Arch Cardiol Mex; 2013; 83(1):45-54. PubMed ID: 23474149
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases.
    Klatzmann D; Abbas AK
    Nat Rev Immunol; 2015 May; 15(5):283-94. PubMed ID: 25882245
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulatory T cells enter the pancreas during suppression of type 1 diabetes and inhibit effector T cells and macrophages in a TGF-beta-dependent manner.
    Tonkin DR; Haskins K
    Eur J Immunol; 2009 May; 39(5):1313-22. PubMed ID: 19404982
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role and mechanisms of double negative regulatory T cells in the suppression of immune responses.
    Chen W; Ford MS; Young KJ; Zhang L
    Cell Mol Immunol; 2004 Oct; 1(5):328-35. PubMed ID: 16285891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.